Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-03-03

EMA Authorised: Spherox (spheroids of human autologous matrix-associated chondrocytes) — CO.DON Gmbh

View source ↗

Summary

The EMA authorised Spherox, comprising spheroids of human autologous matrix-associated chondrocytes, for cartilage diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spherox (spheroids of human autologous matrix-associated chondrocytes)

Snippet

Status: Authorised. Therapeutic area: Cartilage Diseases. MAH: CO.DON Gmbh. Decision date: 27/02/2025